Literature DB >> 20157296

In vivo veritas: the surprising roles of Fc receptors in immunity.

Jeffrey Ravetch1.   

Abstract

Jeffrey Ravetch describes how he came to identify the in vivo function of the once mysterious Fc receptors.

Mesh：

Substances：

Year:  2010        PMID： 20157296     DOI： 10.1038/ni0310-183

Source DB:  PubMed          Journal:  Nat Immunol        ISSN： 1529-2908            Impact factor:   25.606


  31 in total

Review 1.  Immune inhibitory receptors.

Authors:  J V Ravetch; L L Lanier
Journal:  Science       Date:  2000-10-06       Impact factor: 47.728

2.  Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation.

Authors:  Yoshikatsu Kaneko; Falk Nimmerjahn; Jeffrey V Ravetch
Journal:  Science       Date:  2006-08-04       Impact factor: 47.728

3.  Identification of a receptor required for the anti-inflammatory activity of IVIG.

Authors:  Robert M Anthony; Fredrik Wermeling; Mikael C I Karlsson; Jeffrey V Ravetch
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-26       Impact factor: 11.205

4.  Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene.

Authors:  Guillaume Cartron; Laurent Dacheux; Gilles Salles; Philippe Solal-Celigny; Pierre Bardos; Philippe Colombat; Hervé Watier
Journal:  Blood       Date:  2002-02-01       Impact factor: 22.113

5.  A 13-amino-acid motif in the cytoplasmic domain of Fc gamma RIIB modulates B-cell receptor signalling.

Authors:  T Muta; T Kurosaki; Z Misulovin; M Sanchez; M C Nussenzweig; J V Ravetch
Journal:  Nature       Date:  1994-05-26       Impact factor: 49.962

6.  Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis.

Authors:  S Bolland; J V Ravetch
Journal:  Immunity       Date:  2000-08       Impact factor: 31.745

7.  Organization of the human and mouse low-affinity Fc gamma R genes: duplication and recombination.

Authors:  W Q Qiu; D de Bruin; B H Brownstein; R Pearse; J V Ravetch
Journal:  Science       Date:  1990-05-11       Impact factor: 47.728

8.  Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice.

Authors:  T Takai; M Ono; M Hikida; H Ohmori; J V Ravetch
Journal:  Nature       Date:  1996-01-25       Impact factor: 49.962

9.  Evolutionary approach to the question of immunoglobulin heavy chain switching: evidence from cloned human and mouse genes.

Authors:  J V Ravetch; I R Kirsch; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

10.  Immunoglobulin G-mediated inflammatory responses develop normally in complement-deficient mice.

Authors:  D Sylvestre; R Clynes; M Ma; H Warren; M C Carroll; J V Ravetch
Journal:  J Exp Med       Date:  1996-12-01       Impact factor: 14.307
View more
  14 in total

Review 1.  Monoclonal antibodies in cancer therapy.

Authors:  Andrew M Scott; James P Allison; Jedd D Wolchok
Journal:  Cancer Immun       Date:  2012-05-01

Review 2.  Extending the Breadth of Influenza Vaccines: Status and Prospects for a Universal Vaccine.

Authors:  Annette Fox; Kylie M Quinn; Kanta Subbarao
Journal:  Drugs       Date:  2018-09       Impact factor: 9.546

Review 3.  Antibody therapy of cancer.

Authors:  Andrew M Scott; Jedd D Wolchok; Lloyd J Old
Journal:  Nat Rev Cancer       Date:  2012-03-22       Impact factor: 60.716

Review 4.  Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond.

Authors:  P Mark Hogarth; Geoffrey A Pietersz
Journal:  Nat Rev Drug Discov       Date:  2012-03-30       Impact factor: 84.694

5.  IgG keeps virulent Salmonella from evading dendritic cell uptake.

Authors:  Sebastián A Riquelme; Susan M Bueno; Alexis M Kalergis
Journal:  Immunology       Date:  2012-07       Impact factor: 7.397

6.  A novel hemolytic complement-sufficient NSG mouse model supports studies of complement-mediated antitumor activity in vivo.

Authors:  Mohit K Verma; Julia Clemens; Lisa Burzenski; Stephen B Sampson; Michael A Brehm; Dale L Greiner; Leonard D Shultz
Journal:  J Immunol Methods       Date:  2017-04-06       Impact factor: 2.303

Review 7.  Bench-to-bedside review: Immunoglobulin therapy for sepsis - biological plausibility from a critical care perspective.

Authors:  Manu Shankar-Hari; Jo Spencer; William A Sewell; Kathryn M Rowan; Mervyn Singer
Journal:  Crit Care       Date:  2012-12-12       Impact factor: 9.097

8.  Deficiency of activating Fcγ-receptors reduces hepatic clearance and deposition of IC and increases CIC levels in mercury-induced autoimmunity.

Authors:  Klara Martinsson; Thomas Skogh; Seyed Ali Mousavi; Trond Berg; Jan-Ingvar Jönsson; Per Hultman
Journal:  PLoS One       Date:  2010-10-15       Impact factor: 3.240

Review 9.  Immunity and immunopathology to viruses: what decides the outcome?

Authors:  Barry T Rouse; Sharvan Sehrawat
Journal:  Nat Rev Immunol       Date:  2010-07       Impact factor: 53.106

10.  Down-regulation of complement receptors on the surface of host monocyte even as in vitro complement pathway blocking interferes in dengue infection.

Authors:  Cintia Ferreira Marinho; Elzinandes Leal Azeredo; Amanda Torrentes-Carvalho; Alessandro Marins-Dos-Santos; Claire Fernandes Kubelka; Luiz José de Souza; Rivaldo Venâncio Cunha; Luzia Maria de-Oliveira-Pinto
Journal:  PLoS One       Date:  2014-07-25       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.